Peripheral blood: Clinical Trials

22 trials of Peripheral blood, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 5 active not recruiting, 3 recruiting, 2 unknown. 13 Phase 2, 6 Phase 1, 2 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Completed 5, Active not recruiting 4, Recruiting 3, Terminated 1
Phase 16Completed 3, Recruiting 1, Terminated 1, Withdrawn 1
Not applicable2Completed 2
Phase 31Active not recruiting 1

Follow Peripheral blood: new trials by email Literature Review of Peripheral blood trials Research Report on Peripheral blood

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Acute Myeloid Leukemia With Complex Karyotype, Myelodysplastic Chronic Myelomonocytic Leukemia
Phase 2RecruitingCity of Hope Medical Center352026-11-052026-10-08
Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma
Bendamustine, Pralatrexate, Bone Marrow Aspiration - Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma
Phase 1 / Phase 2RecruitingFred Hutchinson Cancer Center502026-04-272026-05-11
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Aplastic Anemia
Phase 2Active not recruitingFred Hutchinson Cancer Center12025-09-252026-05-22
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
Cyclophosphamide, Itacitinib, Peripheral Blood Stem Cell Transplantation - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2Active not recruitingCity of Hope Medical Center202022-12-292026-10-14
S Protein and COVID-19: a Monocentric Prospective Study
Hematolgy and Chemistry analysis, Real Time PCR, PROS assay COVID+ - COVID-19
UnknownUniversity of Milano Bicocca702021-09-232024-01-02
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Biospecimen Collection, Carboplatin, Etoposide - Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma
Phase 2RecruitingChildren's Oncology Group1602021-07-132026-09-23
Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy
AVB-S6-500, Paclitaxel, Carboplatin - Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma
Phase 1WithdrawnWashington University School of Medicine2021-06-302021-09-29
A Study of N-acetylcysteine in Patients With COVID-19 Infection
N-acetylcysteine, Peripheral Blood - Covid-19
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center482020-05-012026-05-01
Palliative Lattice Stereotactic Body Radiotherapy (SBRT)
Lattice stereotactic body radiation therapy, Peripheral blood - Cancer, Palliative Radiotherapy
Not applicableCompletedWashington University School of Medicine202019-10-312021-11-22
Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
Abemaciclib, Nivolumab, Tumor biopsy - Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2TerminatedWashington University School of Medicine62019-05-292020-12-03
Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma
Bendamustine, Rituximab, Acalabrutinib - Mantle Cell Lymphoma
Phase 2CompletedWashington University School of Medicine132018-11-292026-04-21
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
PROSTVAC-V, PROSTVAC-F, Nivolumab - Metastatic Hormone-Sensitive Prostate Cancer
Phase 1CompletedWashington University School of Medicine192018-09-142022-08-05
BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
BMS-813160, Nivolumab, Gemcitabine - Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2CompletedWashington University School of Medicine402018-08-312025-07-29
Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies
peripheral blood - Leukemia
UnknownNational Taiwan University Hospital1302018-03-092018-08-10
Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects
Nasal lavage, Nasal allergen challenge, Epicutaneous skin testing - Nasal Allergy
Not applicableCompletedMitchell Grayson252017-09-062019-10-07
Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation, Busulfan, Gemcitabine Hydrochloride - Plasma Cell Leukemia, Plasmacytoma
Phase 2CompletedM.D. Anderson Cancer Center832015-09-142025-03-18
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
MK-3475 (neoadjuvant), Surgery, Intensity modulated radiation therapy - Cancer of Head and Neck, Head and Neck Cancer
Phase 2CompletedWashington University School of Medicine672015-03-252026-08-05
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Autologous Hematopoietic Stem Cell Transplantation, Busulfan, Cisplatin - Ganglioneuroblastoma, Stage 1 Neuroblastoma
Phase 1CompletedChildren's Oncology Group1502013-04-092024-07-15
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
Fludarabine phosphate, Busulfan, Total-Body Irradiation - Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University622012-12-242025-10-30
Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
Blood samples - Acute Graft-versus-Host Disease, Allogeneic Stem Cell Transplant
CompletedOhio State University Comprehensive Cancer Center2592012-02-202025-01-20

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Leukemia, Myeloid, Acute (3)  ·  Multiple Myeloma (3)  ·  Myelodysplastic Syndromes (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Anemia, Aplastic (2)  ·  COVID-19 (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Primary Myelofibrosis (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Embryonal (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Choriocarcinoma (1)  ·  Fallopian Tube Neoplasms (1)  ·  Ganglioneuroblastoma (1)

Sponsors

Washington University School of Medicine (7)  ·  Children's Oncology Group (2)  ·  City of Hope Medical Center (2)  ·  Fred Hutchinson Cancer Center (2)  ·  National Cancer Institute (NCI) (2)  ·  M.D. Anderson Cancer Center (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Mitchell Grayson (1)  ·  National Taiwan University Hospital (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  University of Milano Bicocca (1)

Countries

United States (19)  ·  Australia (2)  ·  Canada (2)  ·  New Zealand (2)  ·  Italy (1)  ·  Taiwan (1)

Top investigators

Douglas R Adkins, M.D. (2)  ·  Monzr M Al Malki (2)  ·  Brad S Kahl, M.D. (1)  ·  Dolores Grosso, RN, CRNP, DNP (1)  ·  Farhad Ravandi-Kashani (1)  ·  Hannah Choe, MD (1)  ·  Katherine C Fuh, M.D., Ph.D. (1)  ·  Kian-Huat Lim, M.D., Ph.D. (1)  ·  Lorenzo Iovino, MD, PhD (1)  ·  Luisa Verga, MD (1)  ·  Mary Meaghan P Granger (1)  ·  Matthew Spraker, M.D., Ph.D. (1)  ·  Mitchell H Grayson, MD (1)  ·  Neal Flomenberg, MD (1)  ·  Philip L McCarthy (1)

Results publications

PMID 22571201, PMID 28826616, PMID 29618479, PMID 31491537, PMID 32665297, PMID 34195486

NIH funding

P30CA033572 (2), U10CA180886 (2), P50CA196510 (1), R01HL087778 (1), U10CA031946 (1), U10CA032102 (1), U10CA098543 (1), U10CA180821 (1), U10CA180888 (1)